← Back to Screener
US Stock Screener
HomeScreensNewsWatchlist
...

FOXO Technologies Inc. (FOXO) 10-Year Financial Performance & Capital Metrics

FOXO • • Industrial / General
HealthcareHealthcare ITHealthcare Data Analytics & AIAI-Powered Clinical Analytics
AboutFOXO Technologies Inc., a technology platform company, focuses on commercializing longevity science through products and services that serve the life insurance industry. The company is developing products and services that combine longevity science with life insurance to support the consumer health and wellness engagement, and to simplify the consumer underwriting journey. It offers FOXO Labs, a services platform that integrates saliva-based epigenetic biomarkers into accelerated underwriting protocols to improve the customer underwriting journey; and FOXO Life, an insurance products platform that offers proprietary life insurance products and third-party life insurance carrier products based on bundling longevity science with life insurance. The company was founded in 2019 and is based in Minneapolis, Minnesota.Show more
  • Revenue $4M +2688.6%
  • EBITDA -$7M +68.8%
  • Net Income -$12M +53.1%
  • EPS (Diluted) -0.93 +86.9%
  • Gross Margin 38.68% +336.9%
  • EBITDA Margin -161.09% +98.9%
  • Operating Margin -191.58% +98.7%
  • Net Margin -306.21% +98.3%
  • ROE -235.33%
  • ROIC -122.25%
  • Debt/Equity 2.70
  • Interest Coverage -1.98 +90.5%
Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

  • ✓Trading at only 0.0x book value

✗Weaknesses

  • ✗High debt to equity ratio of 2.7x
  • ✗Negative free cash flow
  • ✗Weak momentum: RS Rating 1 (bottom 1%)
  • ✗Low quality earnings: Net income not backed by cash flow
  • ✗Shares diluted 100.0% in last year
  • ✗Trading more than 30% below 52-week high

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-
5Y-
3Y223.21%
TTM1000.47%

Profit (Net Income) CAGR

10Y-
5Y-
3Y-
TTM-3.55%

EPS CAGR

10Y-
5Y-
3Y-
TTM16.78%

ROCE

10Y Avg-364.33%
5Y Avg-364.33%
3Y Avg-245.96%
Latest-86.43%

Peer Comparison

AI-Powered Clinical Analytics
Select Columns
Size & Scale
Valuation
Per Share
Growth
Profitability
Quality & Returns
Safety & Leverage
TTM Growth
Famous Investor Metrics
Dividends
Latest Quarter
Momentum & Returns
Total Return (DRIP)
Technical
Volume & Trading
Shares & Dilution
Sector-Specific
NameMarket CapCurrent PriceP/E RatioRevenue Growth 1YNet MarginROEFCF YieldDebt/Equity
FOXOFOXO Technologies Inc.175.02K0.00-0.0026.89%-66.46%-48.71%2.70
HCTIHealthcare Triangle, Inc.3.27M0.45-0.00-64.77%-48.85%-72.45%
BFRGWBullfrog AI Holdings, Inc. Warrants2.05M0.20-0.23-100%-57.71%-346.39%
BFRGBullfrog AI Holdings, Inc. Common Stock8.66M0.76-0.89-100%-57.71%-346.39%

Profit & Loss

Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Sales/Revenue+63K120K511K145.29K4.05M
Revenue Growth %-0.9%3.26%-0.72%26.89%
Cost of Goods Sold+00344K132.43K2.48M
COGS % of Revenue--0.67%0.91%0.61%
Gross Profit+63K120K167K12.86K1.57M
Gross Margin %1%1%0.33%0.09%0.39%
Gross Profit Growth %-0.9%0.39%-0.92%120.84%
Operating Expenses+8.79M15.15M40.33M22.2M9.33M
OpEx % of Revenue139.57%126.26%78.93%152.8%2.3%
Selling, General & Admin6.89M10.27M25.83M19.4M7.17M
SG&A % of Revenue109.44%85.6%50.54%133.52%1.77%
Research & Development1.9M4.88M3.05M900.43K312.27K
R&D % of Revenue30.13%40.66%5.96%6.2%0.08%
Other Operating Expenses0011.46M1.9M1.85M
Operating Income+-8.73M-15.03M-40.17M-22.19M-7.76M
Operating Margin %-138.57%-125.26%-78.6%-152.71%-1.92%
Operating Income Growth %--0.72%-1.67%0.45%0.65%
EBITDA+-7.46M-14.93M-38.65M-20.91M-6.53M
EBITDA Margin %-118.49%-124.44%-75.64%-143.91%-1.61%
EBITDA Growth %--1%-1.59%0.46%0.69%
D&A (Non-Cash Add-back)1.26M98K1.51M1.28M1.24M
EBIT-8.73M-37.37M-93.81M-25.39M-8.51M
Net Interest Income+61K-1.12M-1.44M-1.06M-3.91M
Interest Income61K0000
Interest Expense01.12M1.44M1.06M3.91M
Other Income/Expense77K-23.46M-55.09M-4.26M-4.66M
Pretax Income+-8.65M-38.49M-95.25M-26.45M-12.42M
Pretax Margin %-137.35%-320.73%-186.41%-182.05%-3.07%
Income Tax+00000
Effective Tax Rate %1%1%1%1%1%
Net Income+-8.65M-38.49M-95.25M-26.45M-12.41M
Net Margin %-137.35%-320.73%-186.41%-182.05%-3.06%
Net Income Growth %--3.45%-1.47%0.72%0.53%
Net Income (Continuing)-8.65M-38.49M-95.25M-26.45M-12.42M
Discontinued Operations00000
Minority Interest0000-51.94K
EPS (Diluted)+-43.27-66.13-84.00-7.08-0.93
EPS Growth %--0.53%-0.27%0.92%0.87%
EPS (Basic)-43.27-66.13-84.00-7.08-0.93
Diluted Shares Outstanding200K582K1.13M4.22M14.61M
Basic Shares Outstanding200K582K1.13M3.74M13.37M
Dividend Payout Ratio-----

Balance Sheet

Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Total Current Assets+8.59M7.62M12.3M233K2.88M
Cash & Short-Term Investments8.12M6.86M5.51M38K68.27K
Cash Only8.12M6.86M5.51M38K68.27K
Short-Term Investments00000
Accounts Receivable00100K100K2.27M
Days Sales Outstanding--71.43251.22204.59
Inventory0295K1.31M0161.47K
Days Inventory Outstanding--1.39K-23.72
Other Current Assets12K23K14K9K89.56K
Total Non-Current Assets+830K22.69M23.1M492K38.83M
Property, Plant & Equipment167K187K004.35B
Fixed Asset Turnover0.38x0.64x--0.00x
Goodwill000025.46M
Intangible Assets0191K2.04M378K9.02M
Long-Term Investments419K100K000
Other Non-Current Assets244K2.75M21.06M114K-4.34B
Total Assets+9.42M30.3M35.41M725K41.71M
Asset Turnover0.01x0.00x0.01x0.20x0.10x
Asset Growth %-2.22%0.17%-0.98%56.53%
Total Current Liabilities+614K36.06M6.91M14.34M32.73M
Accounts Payable366K3.46M3.47M4.56M6.68M
Days Payables Outstanding--3.68K12.56K981.02
Short-Term Debt032.2M1.41M4.2M10.22M
Deferred Revenue (Current)00000
Other Current Liabilities0003.88M8.32M
Current Ratio14.00x0.21x1.78x0.02x0.09x
Quick Ratio14.00x0.20x1.59x0.02x0.08x
Cash Conversion Cycle---2.21K--752.71
Total Non-Current Liabilities+90K19.46M21.79M489K3.71M
Long-Term Debt001.73M00
Capital Lease Obligations00003.67M
Deferred Tax Liabilities00000
Other Non-Current Liabilities90K12.42M20.06M489K41.25K
Total Liabilities704K55.52M28.7M14.82M36.44M
Total Debt+032.2M3.14M4.2M14.25M
Net Debt-8.12M25.35M-2.38M4.17M14.19M
Debt / Equity--0.47x-2.70x
Debt / EBITDA-----
Net Debt / EBITDA-----
Interest Coverage--13.44x-27.89x-20.86x-1.98x
Total Equity+8.72M-25.22M6.71M-14.1M5.27M
Equity Growth %--3.89%1.27%-3.1%1.37%
Book Value per Share43.60-43.335.92-3.340.36
Total Shareholders' Equity8.72M-25.22M6.71M-14.1M5.32M
Common Stock003K1K2.36K
Retained Earnings-13.49M-51.98M-147.23M-177.06M-190.54M
Treasury Stock00000
Accumulated OCI00000
Minority Interest0000-51.94K

Cash Flow

Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Cash from Operations+-481.43K-15.05M-23.76M-6.64M-2.84M
Operating CF Margin %-7.64%-125.46%-46.5%-45.74%-0.7%
Operating CF Growth %--30.27%-0.58%0.72%0.57%
Net Income-1.78M-38.49M-95.25M-26.45M-12.42M
Depreciation & Amortization098K1.51M1.28M1.24M
Stock-Based Compensation0131K11.04M381K-101.73K
Deferred Taxes0400K000
Other Non-Cash Items1.75M22.23M62.3M10.13M5.67M
Working Capital Changes-443.18K572K-3.35M8.02M2.78M
Change in Receivables0-1.92M890K18.57M553.93K
Change in Inventory0-295K-1.02M1.31M40.27K
Change in Payables03.09M127K1.3M1.16M
Cash from Investing+-201.25M-355K-1.87M013.33K
Capital Expenditures0-242K-110K00
CapEx % of Revenue0%2.02%0.22%--
Acquisitions-----
Investments-----
Other Investing0-50K-1.76M00
Cash from Financing+203.2M14.14M24.29M1.17M2.86M
Debt Issued (Net)-----
Equity Issued (Net)-----
Dividends Paid00000
Share Repurchases-----
Other Financing50K3.64M-6.01M-299K-42K
Net Change in Cash-----
Free Cash Flow+-481.42K-15.3M-25.63M-6.64M-2.84M
FCF Margin %-7.64%-127.47%-50.16%-45.74%-0.7%
FCF Growth %--30.77%-0.68%0.74%0.57%
FCF per Share-2.41-26.28-22.60-1.58-0.19
FCF Conversion (FCF/Net Income)0.06x0.39x0.25x0.25x0.23x
Interest Paid001.22M00
Taxes Paid00000

Key Ratios

Metric20202021202220232024
Return on Equity (ROE)-99.23%--1420.02%--235.33%
Return on Invested Capital (ROIC)--3114.16%-1351.21%--122.25%
Gross Margin100%100%32.68%8.85%38.68%
Net Margin-13734.92%-32073.33%-18640.9%-18205.21%-306.21%
Debt / Equity--0.47x-2.70x
Interest Coverage--13.44x-27.89x-20.86x-1.98x
FCF Conversion0.06x0.39x0.25x0.25x0.23x
Revenue Growth-90.48%325.83%-71.57%2688.61%

Frequently Asked Questions

Growth & Financials

FOXO Technologies Inc. (FOXO) reported $14.8M in revenue for fiscal year 2024. This represents a 23324% increase from $0.1M in 2020.

FOXO Technologies Inc. (FOXO) grew revenue by 2688.6% over the past year. This is strong growth.

FOXO Technologies Inc. (FOXO) reported a net loss of $9.8M for fiscal year 2024.

Dividend & Returns

FOXO Technologies Inc. (FOXO) has a return on equity (ROE) of -235.3%. Negative ROE indicates the company is unprofitable.

FOXO Technologies Inc. (FOXO) had negative free cash flow of $5.7M in fiscal year 2024, likely due to heavy capital investments.

VCP Scanner

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screens
  • Valuation
  • Compare
  • Total Return
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Twitter
  • Get Early Access
© 2026 VCP Scanner. All rights reserved.
Made with ❤️ for investors
Not financial advice. Do your own research.